Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Trial Evaluating Plerixafor-based Mobilization and Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation

NCT07188090 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT07188090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Trial Evaluating Plerixafor-based Mobilization and Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Recruiting
Start date
October 16, 2025
Completion date
June 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, multiple myeloma, non-hodgkin lymphoma